These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 9793973)
21. Antenatal diagnosis of fetal digestive (sub)obstruction. Ultrasonic semeiology and follow-up. Avni EF; Van Gansbeke D; Matos C; Houben JJ; Delaet MH; Rodesch F J Belge Radiol; 1986; 69(4):241-6. PubMed ID: 3531160 [No Abstract] [Full Text] [Related]
22. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome. Gross SJ; Phillips OP; Shulman LP; Bright NL; Dungan JS; Simpson JL; Elias S Prenat Diagn; 1994 Jul; 14(7):609-13. PubMed ID: 7526367 [TBL] [Abstract][Full Text] [Related]
23. Characteristic findings for diagnosis of baby complicated with both the VACTERL association and duodenal atresia. Fujishiro E; Suzuki Y; Sato T; Kondo S; Miyachi M; Suzumori K Fetal Diagn Ther; 2004; 19(2):134-7. PubMed ID: 14764957 [TBL] [Abstract][Full Text] [Related]
24. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age. MacDonald ML; Wagner RM; Slotnick RN Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526 [TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal disorders in Down syndrome. Bermudez BEBV; de Oliveira CM; de Lima Cat MN; Magdalena NIR; Celli A Am J Med Genet A; 2019 Aug; 179(8):1426-1431. PubMed ID: 31183986 [TBL] [Abstract][Full Text] [Related]
27. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs. Ashwood ER; Cheng E; Luthy DA Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476 [TBL] [Abstract][Full Text] [Related]
28. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies. Hsu JJ; Hseih TT; Liou JD; Soong YK J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053 [TBL] [Abstract][Full Text] [Related]
34. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome]. Liao S; Wang Y; Ye G Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764 [TBL] [Abstract][Full Text] [Related]
35. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death. Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912 [TBL] [Abstract][Full Text] [Related]
36. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [TBL] [Abstract][Full Text] [Related]
37. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center. Cariati E; Brizzi L; Periti E J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428 [TBL] [Abstract][Full Text] [Related]
38. Gestational age at maternal serum alpha-fetoprotein screening and the detection of Down syndrome. Waller K; Lustig L; Hook E Am J Hum Genet; 1990 Sep; 47(3):581-3. PubMed ID: 1697446 [No Abstract] [Full Text] [Related]